OTC Markets OTCQB - Delayed Quote USD

NIKA PHARMACEUTICALS INC. (NIKA)

Compare
0.5900 +0.0828 (+16.32%)
At close: January 7 at 7:00:00 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
90.6530
64.8330
3,183.7150
14.7120
8.9070
Operating Income
-90.6530
-64.8330
-3,183.7150
-14.7120
-8.9070
Pretax Income
-90.6530
-64.8330
-3,183.7150
-14.7120
-8.9070
Net Income Common Stockholders
-90.6530
-64.8330
-3,183.7150
-14.7120
-8.9070
Diluted NI Available to Com Stockholders
-90.6530
-64.8330
-3,183.7150
-14.7120
-8.9070
Basic EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Diluted EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Basic Average Shares
1,018,519.5000
876,090.0000
876,090.0000
876,090.0000
876,090.0000
Diluted Average Shares
1,018,519.5000
876,090.0000
876,090.0000
876,090.0000
876,090.0000
Total Operating Income as Reported
-90.6530
-64.8330
-3,183.7150
-14.7120
-8.9070
Total Expenses
90.6530
64.8330
3,183.7150
14.7120
8.9070
Net Income from Continuing & Discontinued Operation
-90.6530
-64.8330
-3,183.7150
-14.7120
-8.9070
Normalized Income
-90.6530
-64.8330
-3,183.7150
-14.7120
-8.9070
EBIT
-90.6530
-64.8330
-3,183.7150
-14.7120
-8.9070
EBITDA
-90.6530
-64.8330
-3,183.7150
-14.7120
-8.9070
Net Income from Continuing Operation Net Minority Interest
-90.6530
-64.8330
-3,183.7150
-14.7120
-8.9070
Normalized EBITDA
-90.6530
-64.8330
-3,183.7150
-14.7120
-8.9070
12/31/2020 - 3/14/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers